Max Strength Mucinex Sales Could Reach $70M In Debut Season – Adams
This article was originally published in The Tan Sheet
Executive Summary
Adams Respiratory Therapeutics projects sales of its forthcoming Maximum Strength Mucinex products will eventually make up 60 percent of total Mucinex sales, the firm said April 4
You may also be interested in...
Reckitt Raises Guidance On Adams Performance, Marketing Momentum
Reckitt Benckiser raises its 2008 sales targets based on the performance of brands added with its acquisition of Adams Respiratory Therapeutics early this year and heavy marketing investment in its latest quarter
Reckitt Raises Guidance On Adams Performance, Marketing Momentum
Reckitt Benckiser raises its 2008 sales targets based on the performance of brands added with its acquisition of Adams Respiratory Therapeutics early this year and heavy marketing investment in its latest quarter
Reckitt Raises Guidance On Adams Performance, Marketing Momentum
Reckitt Benckiser raises its 2008 sales targets based on the performance of brands added with its acquisition of Adams Respiratory Therapeutics early this year and heavy marketing investment in its latest quarter